Cryo-Cell International (Cryo-Cell International) GF Value Rank : 3 (As of May. 03, 2024)

View and export this data going back to . Start your Free Trial

What is Cryo-Cell International GF Value Rank?

Cryo-Cell International has the GF Value Rank of 3.

The GF Value Rank is determined by the price-to-GF-Value (P/GF Value) ratio, a proprietary metric calculated based on historical multiples along with an adjustment factor based on a company's past returns and growth and future estimates of the business' performance.

GuruFocus found that for valuation, we cannot simply give stocks a better GF Value rank simply because they have a lower P/GF Value ratio. Backtesting shows that over the long term, the two worst-performing groups are the most expensive group (with the highest P/GF Value ratio) and the least expensive group (with the lowest P/GF Value ratio).

We can understand why the most expensive group underperforms. We were initially puzzled by the underperformance of the least expensive group, but we realized there is a reason why some stocks are super cheap. If they look too undervalued, it is often because the businesses behind them are poor quality. The market realized this and gave them low valuations. In a way, the market is efficient.

After multiple backtesting analyses, we granted the stocks in third-cheapest percentile the highest GF Value rank, as they have performed the best over a full market cycle. Stock performance is actually not as sensitive to valuation as it is to growth and profitability. On average, the companies in the 20%-50% valuation groups have similar performances. Therefore, we should avoid the most expensive and the least expensive stocks. We can be more tolerant of valuation.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Competitive Comparison of Cryo-Cell International's GF Value Rank

For the Medical Care Facilities subindustry, Cryo-Cell International's GF Value Rank, along with its competitors' market caps and GF Value Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cryo-Cell International's GF Value Rank Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Cryo-Cell International's GF Value Rank distribution charts can be found below:

* The bar in red indicates where Cryo-Cell International's GF Value Rank falls into.

Cryo-Cell International GF Value Rank Related Terms

Thank you for viewing the detailed overview of Cryo-Cell International's GF Value Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Cryo-Cell International (Cryo-Cell International) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Cryo-Cell International Inc (AMEX:CCEL) » Definitions » GF Value Rank

Comparable Companies

Traded in Other Exchanges

ZCY:Germany

Address

700 Brooker Creek Boulevard, Suite 1800, Oldsmar, FL, USA, 34677

Website

https://www.cryo-cell.com

Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of Prepacyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. All the business activity of the group functions through the United States and it derives revenue from processing and testing fees and storage fees charged each year for storage and through sales of the Prepacyte CB units.

Executives

David Portnoy	director, officer: Co-Chief Executive Officer	C/O FOCUS FINANCIAL GROUP, 61 HARBOUR WAY, BAL HARBOUR FL 33154
George Gaines	director	700 BROOKER CREEK BLVD, SUITE 1800, OLDSMAR FL 34677
Jonathan H. Wheeler	director	700 BROOKER CREEK BLVD, SUITE 1800, OLDSMAR FL 34677
Brian L. Sheehy	director	415 MADISON AVENUE, 14TH FLOOR, NEW YORK NY 10017
Mark L. Portnoy	director, officer: Co-Chief Executive Officer	700 BROOKER CREEK BLVD, SUITE 1800, OLDSMAR FL 34677
Harold D. Berger	director	700 BROOKER CREEK BLVD, SUITE 1800, OLDSMAR FL 34677
Arthur Ellis	director	700 BROOKER CREEK BLVD, SUITE 1800, OLDSMAR FL 34677
Mary J Nyberg	10 percent owner	455 E MAYO BLVD, UNIT 5202, PHOENIX AZ 85050
Cdmj Nyberg Family Trust	10 percent owner	455 E MAYO BLVD, UNIT 5202, PHOENIX AZ 85050
Jill M Taymans	officer: VP, Finance, CFO
Oleg Mikulinsky	officer: Chief Information Officer	700 BROOKER CREEK BLVD., SUITE 1800, OLDSMAR FL 34677
Anthony Atala	director	700 BROOKER CREEK BOULEVARD, OLDSMAR FL 34677
Scott G Christian	director
Sung Won Sohn	director	700 BROOKER CREEK BLVD., SUITE 1800, OLDSMAR FL 34677
Michael W. Cho	director	C/O IOWA STATE UNIVERSITY, 1600 S. 16TH STREET, AMES IA 50011-1250